Inhibrx Biosciences Inc News - INBX | ADVFN

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Inhibrx Biosciences Inc (INBX)
Inhibrx Biosciences Inc (INBX) News

Inhibrx Biosciences Inc (INBX)

13.73

0.30

(2.23%)

Closed July 26 4:00PM

Delayed by 15 minutes

13.73

0.00

(0.00%)

After Hours: 4:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ)

US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) Epazz, Inc. (OTC Pink: EPAZ) is making remarkable strides with its holdings...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Airbus, PHI Group Sign Deal for 28 Helicopters

By Mauro Orru Airbus's helicopter unit signed a framework agreement with PHI Group that includes firm orders and purchase options for 28...

1
Next

Monksdream

Monksdream 4 months ago

TrendTrade2016

TrendTrade2016 2 years ago

heres the dolla...boom!!

TrendTrade2016

TrendTrade2016 2 years ago

INBX DOLLA RUMMER IN PROCESS

TrendTrade2016

TrendTrade2016 2 years ago

INBX...PRE MARKET VOL

Jaydixson1

Jaydixson1 2 years ago

Seems to be dropping

make it happen

make it happen 2 years ago

Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M

Inhibrx Biosciences

Delayed Upgrade Clock